XML 38 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Borrowings
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Borrowings Borrowings
Federal Home Loan Bank Advances
Advances payable to FHLB amounted to $145.0 million and $593.9 million, respectively, at December 31, 2021 and 2020.

As of December 31, 2021 and 2020, the Bank had access to a $40.0 million unused line of credit and also had remaining available borrowing capacity of $1.6 billion and $969.7 million, respectively with the FHLB. The Bank pledges certain qualified investment securities and loans as collateral to the FHLB.
The following table presents maturities and weighted average interest rates on FHLB advances outstanding as of December 31, 2021:
(Dollars in thousands)Scheduled
Maturity		Weighted
Average Rate
2022$110,000 0.35 %
202335,000 0.45 
2024— — 
2025— — 
2026— — 
2027 and thereafter— — 
Total$145,000 0.38 %
Junior Subordinated Debentures
Junior subordinated debentures amounted to $22.7 million at December 31, 2021 and 2020.

The Bancorp sponsored the creation of WT Capital Trust I (“Trust I”) and WT Capital Trust II (“Trust II”), Delaware statutory trusts created for the sole purpose of issuing trust preferred securities and investing the proceeds in junior subordinated debentures of the Bancorp.  The Bancorp is the owner of all of the common securities of the trusts.  In accordance with GAAP, the trusts are treated as unconsolidated subsidiaries.

The $8.3 million of junior subordinated debentures associated with Trust I bear interest at a rate equal to the three-month LIBOR rate plus 1.45% and mature on September 15, 2035.  The $14.4 million of junior subordinated debentures associated with Trust II bear interest at a rate equal to the three-month LIBOR rate plus 1.45% and mature on November 23, 2035. The debentures may be redeemed at par at the Bancorp’s option, subject to the approval of the applicable banking regulator to the extent required under applicable guidelines or policies.

See Note 13 for additional discussion of the regulatory capital treatment of trust preferred securities.